Effect of of MPC-11 myeloma and MPC-11+IL-1 receptor antagonist treatment on mouse bone properties
Journal Article
Overview
publication date
- January 1, 2002
has subject area
- Animals
- Animals, Inbred Strains - Mice, Inbred BALB C
- Biological Factors - Interleukin 1 Receptor Antagonist Protein
- Biological Factors - Interleukin-1
- Biological Factors - Interleukin-1
- Biological Factors - Interleukin-6
- Blood Protein Disorders - Multiple Myeloma
- Bone Density
- Bone Diseases - Bone Resorption
- Connective Tissue - Bone and Bones
- Female
- Hemorrhagic Disorders - Multiple Myeloma
- Hyaluronic Acid
- Immunoproliferative Disorders - Multiple Myeloma
- Immunoproliferative Disorders - Multiple Myeloma
- Mice
- Mice - Mice, Inbred BALB C
- Musculoskeletal Physiological Phenomena - Bone Resorption
- Neoplasms, Plasma Cell - Multiple Myeloma
- Peptides - Interleukin 1 Receptor Antagonist Protein
- Peptides - Interleukin-1
- Peptides - Interleukin-1
- Peptides - Interleukin-6
- Peptides - Sialoglycoproteins
- Proteins - Interleukin 1 Receptor Antagonist Protein
- Proteins - Interleukin-1
- Proteins - Interleukin-1
- Proteins - Interleukin-6
- Proteins - Sialoglycoproteins
- Skeleton - Bone and Bones
- Vascular Diseases - Multiple Myeloma
has restriction
- closed
Date in CU Experts
- September 3, 2013 12:54 PM
Full Author List
- Ferguson VL; Simske SJ; Ayers RA; Bateman TA; Wang HT; Bendele A; Rich B; Collins D; Scherrer J; Sennello R
author count
- 11
citation count
- 6
published in
- Bone Journal
Other Profiles
International Standard Serial Number (ISSN)
- 8756-3282
Electronic International Standard Serial Number (EISSN)
- 1873-2763
Digital Object Identifier (DOI)
Additional Document Info
start page
- 109
end page
- 116
volume
- 30
issue
- 1